Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherCONTINUING EDUCATION

90Y-Ibritumomab Tiuxetan in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma

Darlene M. Fink-Bennett and Kathy Thomas
Journal of Nuclear Medicine Technology June 2003, 31 (2) 61-68;
Darlene M. Fink-Bennett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathy Thomas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 31 no. 2 61-68
PubMed 
12777454

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Published online June 1, 2003.

Copyright & Usage 
© 2003

Author Information

  1. Darlene M. Fink-Bennett, MD 1 and
  2. Kathy Thomas, MHA, CNMT 2
  1. 1Department of Nuclear Medicine, William Beaumont Hospital, Royal Oak, Michigan;
  2. 2Department of Nuclear Medicine, City of Hope National Medical Center, Duarte, California
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2003 to April 2025

AbstractFullPdf
May 20038123
Jun 200358190412
Jul 200370165296
Aug 200334126286
Sep 200338111318
Oct 200337141288
Nov 20032597152
Dec 200324132134
Jan 20041612682
Feb 2004138956
Mar 20042010255
Apr 20043110058
May 20044814356
Jun 20045411843
Jul 20046912021
Aug 20046611723
Sep 2004489731
Oct 2004329728
Nov 2004368327
Dec 2004268326
Jan 2005289321
Feb 2005208326
Mar 2005247525
Apr 2005147225
May 200517418
Jun 2005153717
Jul 200518358
Aug 2005152712
Sep 2005174020
Oct 2005124719
Nov 2005145427
Dec 2005134212
Jan 2006154512
Feb 2006174910
Mar 200695014
Apr 20065339
May 200653815
Jun 200622711
Jul 20062227
Aug 200683216
Sep 200653119
Oct 200654022
Nov 200674521
Dec 200682018
Jan 200792614
Feb 200712125
Mar 200752420
Apr 2007123019
May 200792319
Jun 200733517
Jul 200732531
Aug 200773118
Sep 200742718
Oct 20074236
Nov 200772912
Dec 200781711
Jan 200841912
Feb 200852710
Mar 200832015
Apr 200872517
May 200874515
Jun 200854312
Jul 20083258
Aug 2008154916
Sep 200810338
Oct 20084265
Nov 200815445
Dec 200873110
Jan 200931411
Feb 20093158
Mar 200983012
Apr 200983815
May 200992913
Jun 20096267
Jul 200991915
Aug 20092216
Sep 200922514
Oct 200942023
Nov 200922032
Dec 200951318
Jan 201011229
Feb 201031838
Mar 201041748
Apr 201021634
May 201053317
Jun 201002125
Jul 201011720
Aug 201021915
Sep 201032211
Oct 201053618
Nov 201021615
Dec 201032610
Jan 201131315
Feb 20113259
Mar 201145213
Apr 201143114
May 201131910
Jun 201117196
Jul 2011182315
Aug 2011161521
Sep 2011321516
Oct 2011192112
Nov 2011273024
Dec 2011182817
Jan 2012102212
Feb 201214278
Mar 2012173210
Apr 2012281314
May 20126319
Jun 20128227
Jul 2012313514
Aug 20126147
Sep 201262237
Oct 2012511416
Nov 2012412714
Dec 2012231516
Jan 201319118
Feb 201338911
Mar 20132896
Apr 201330917
May 2013211415
Jun 20131926
Jul 20131133
Aug 201321812
Sep 201341614
Oct 201315138
Nov 2013172217
Dec 2013221515
Jan 201481212
Feb 20141375
Mar 20149410
Apr 201491621
May 20141313
Jun 20142069
Jul 201461012
Aug 201416613
Sep 2014161211
Oct 20149147
Nov 2014231116
Dec 201412610
Jan 20156711
Feb 20151510
Mar 20151459
Apr 20151459
May 2015247
Jun 2015753
Jul 20153920
Aug 20151049
Sep 201523811
Oct 20157713
Nov 20155616
Dec 20156106
Jan 201651613
Feb 201612712
Mar 201661020
Apr 201671417
May 2016281123
Jun 20166916
Jul 2016162019
Aug 2016131815
Sep 201672517
Oct 201641423
Nov 201614329
Dec 2016107975
Jan 2017132311
Feb 201717157
Mar 20174167
Apr 20177130
May 20175246
Jun 20174166
Jul 201711218
Aug 20177200
Sep 20177137
Oct 20178197
Nov 201711175
Dec 201712160
Jan 20187167
Feb 20186111
Mar 20189126
Apr 20183165
May 20181175
Jun 20181164
Jul 20181154
Aug 20180203
Sep 20181121
Oct 20180142
Nov 20182216
Dec 20180222
Jan 201931359
Feb 2019123161
Mar 2019439183
Apr 2019421169
May 2019323189
Jun 2019118168
Jul 2019179137
Aug 2019116181
Sep 2019014192
Oct 201971479
Nov 20197147
Dec 201931110
Jan 20201176
Feb 20203109
Mar 202081313
Apr 2020101412
May 202002011
Jun 20208247
Jul 20203203
Aug 202021913
Sep 202012311
Oct 202072110
Nov 2020589
Dec 20203176
Jan 2021297
Feb 20212611
Mar 20212710
Apr 20213238
May 202112010
Jun 20213239
Jul 20212144
Aug 20215145
Sep 20212206
Oct 202121521
Nov 202131516
Dec 202121917
Jan 20227169
Feb 20222176
Mar 20227114
Apr 20223144
May 202281810
Jun 2022112104
Jul 20222111
Aug 20221136
Sep 20223199
Oct 2022283
Nov 202222412
Dec 2022238
Jan 20231128
Feb 20235222
Mar 202341925
Apr 202343511
May 20238338
Jun 20234113
Jul 202321910
Aug 20234163
Sep 20234233
Oct 20233256
Nov 20231275
Dec 202325511
Jan 20240373
Feb 20240272
Mar 20243142
Apr 20243309
May 202454315
Jun 20245249
Jul 20241259
Aug 20248340
Sep 20243439
Oct 20241274
Nov 20241147
Dec 202423010
Jan 20252178
Feb 20254897
Mar 2025410311
Apr 202576118
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 31 (2)
Journal of Nuclear Medicine Technology
Vol. 31, Issue 2
June 1, 2003
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
90Y-Ibritumomab Tiuxetan in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
90Y-Ibritumomab Tiuxetan in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma
Darlene M. Fink-Bennett, Kathy Thomas
Journal of Nuclear Medicine Technology Jun 2003, 31 (2) 61-68;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
90Y-Ibritumomab Tiuxetan in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma
Darlene M. Fink-Bennett, Kathy Thomas
Journal of Nuclear Medicine Technology Jun 2003, 31 (2) 61-68;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • RATIONALE FOR IBRITUMOMAB TIUXETAN
    • USE OF IBRITUMOMAB TIUXETAN
    • IMAGING AND THERAPY PROTOCOL
    • RADIOPHARMACEUTICAL ACQUISITION, CALIBRATION, AND STORAGE
    • DOSE CALCULATION AND ADMINISTRATION
    • IBRITUMOMAB TIUXETAN IMAGING AND THERAPY PROTOCOL
    • SAFETY OF IBRITUMOMAB TIUXETAN
    • PATIENT DISCHARGE INSTRUCTIONS
    • CODING AND REIMBURSEMENT
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 89Zr as a PET Surrogate Radioisotope for Scouting Biodistribution of the Therapeutic Radiometals 90Y and 177Lu in Tumor-Bearing Nude Mice After Coupling to the Internalizing Antibody Cetuximab
  • Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies
  • Google Scholar

More in this TOC Section

  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • PET/CT Case Series: Unmasking the Mystery of Cardiac Sarcoidosis
  • Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure
Show more Continuing Education

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire